[1] AKINYEMIJU T, ABERA S, AHMED M, et al. The burden of primary liver cancer and underlying etiologies from 1990 to2015 at the global, regional, and national level:Results from the global burden of disease study 2015[J]. JAMA Oncol, 2017, 3 (12) :1683-1691.
|
[2] TORZILLI G, BELGHITI J, KOKUDO N, et al. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers[J]. Ann Surg, 2013, 257 (5) :929-937.
|
[3] LIU J, GAO CD, ZHANG LX. Influence of neutrophil-lymphocyte ratio on prognosis of liver cancer:A meta-analysis[J].J Clin Hepatol, 2017, 33 (7) :1305-1309. (in Chinese) 刘健, 高驰丹, 张立鑫, 等.中性粒细胞与淋巴细胞比值对肝癌预后影响的Meta分析[J].临床肝胆病杂志, 2017, 33 (7) :1305-1309.
|
[4] CHEN K, ZHAN MX, HU BS, et al. Combination of the neutrophil to lymphocyte ratio and the platelet to lymphocyte ratio as a useful predictor for recurrence following radiofrequency ablation of hepatocellular carcinoma[J]. Oncol Lett, 2018, 15 (1) :315-323.
|
[5] LI YF, NIE RC, WU T, et al. Prognostic value of the nutritional risk screening 2002 scale in metastatic gastric cancer:A large-scale cohort study[J]. J Cancer, 2019, 10 (1) :112-119.
|
[6] IILLA P, MARCELA T, JANA S. Screening of malnutrition risk versus indicators of nutritional status and systemic inflammatory response in newly diagnosed lung cancer patients[J]. Klin Onkol, 2014, 27 (4) :261-268.
|
[7] WANG J, YU BQ, YE YJ, et al. Predictive value of nutritional risk screening 2002 and prognostic nutritional index for esophageal cancer patients undergoing definitive radiochemotherapy[J]. Nutr Cancer, 2018, 70 (6) :879-885.
|
[8] CHUA DW, XIN KY, XIN LY, et al. Pre-operative predictors of early recurrence/mortality including the role of inflammatory indices in patients undergoing partial hepatectomy for spontaneously ruptured hepatocellular carcinoma[J]. J Surg Oncol, 2018, 118 (8) :1227-1236.
|
[9] Liver Surgery Group, Surgical Society of Chinese Medical Association. Expert consensus on selection of surgical treatments for hepatocellular carcinoma (2016 3rd edition) [J]. Chin J Dig Surg, 2017, 16 (2) :113-115. (in Chinese) 中华医学会外科学分会肝脏外科学组.肝细胞癌外科治疗方法的选择专家共识 (2016年第3次修订) [J].中华消化外科杂志, 2017, 16 (2) :113-115.
|
[10] KONDRUP J, RASMUSSE HH, HAMBERG O, et al. Nutritional risk screening (NRS 2002) :A new method based on an analysis of controlled clinical trials[J]. Clin Nutr, 2003, 22 (3) :321-336.
|
[11] LIU AX, WANG HQ, BO WT, et al. Clinical efficacy and prognostic factors analysis of hepatectomy for hepatocellular carcinoma[J]. Chin J Dig Surg, 2019, 18 (4) :368-374. (in Chinese) 刘爱祥, 王海清, 薄文滔, 等.肝细胞癌肝切除术的临床疗效及预后因素分析[J].中华消化外科杂志, 2019, 18 (4) :368-374.
|
[12] OMATE M, LESMANA LA, TATEISHI R, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma[J]. Hepatol Int, 2010, 4 (2) :439-474.
|
[13] ZHANG TT, ZHAO XQ, LIU Z, et al. Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy:A retrospective study of 601 Chinese patients[J].Clin Transl Oncol, 2016, 18 (8) :831-840.
|
[14] ARENDS JJ. ESPEN guidelines on nutrition in cancer patients[J]. Clin Nutr, 2017, 36 (1) :11-48.
|
[15] WOO SM, PARK JW, LEE WJ, et al. Clinical and virological responses to clevudine therapy of hepatocelluar carcinoma patients with chronic hepatitis B[J]. Gut Liver, 2011, 5 (1) :82-87.
|
[16] HAN B, DING YT, BIAN XJ, et al. Clinical value of preoperative nutritional support therapy in the hepatectomy of patients with nutritional risk:A prospective study[J]. Chin J Dig Surg, 2017, 16 (12) :1183-1190. (in Chinese) 韩冰, 丁义涛, 卞晓洁, 等.术前营养支持治疗在有营养风险患者肝切除术中临床价值的前瞻性研究[J].中华消化外科杂志, 2017, 16 (12) :1183-1190.
|
[17] SCHUTTE K, TIPPELT B, SCHULZ C, et al. Malnutrition is a prognostic factor in patients with hepatocellular carcinoma (HCC) [J]. Clin Nutr, 2014, 34 (6) :1122-1127.
|
[18] ALESSIO M, SHEEVA J, VALENTINA M. The challenges of nutritional assessment in cirrhosis[J]. Curr Nutr Rep, 2017, 6 (3) :274-280.
|
[19] TANDON P, RAMAN M, MOURTZAKIS M, et al. A practical approach to nutritional screening and assessment in cirrhosis[J]. Hepatology, 2016, 65 (3) :1044-1057.
|
[20] KIM JH, SINN DH, GWAK GY, et al. Insulin resistance assessment is useful in risk stratification of hepatocellular carcinoma in chronic hepatitis B patients[J]. J Gastroenterol Hepatol, 2017, 32 (5) :1100-1106.
|